Century Therapeutics (IPSC)

• Market cap: $51.3M
• 1 day: 1.94%
• 5 days: -0.18%
• 1 month: 15.8%
• 3 months: 5.22%
• 6 months: 5.93%
• Year to date: -42.85%
• 1 year: -52.83%
• 5 years: -97.4%
• 10 years: -97.4%
• Sector: Healthcare
• Industry: Biotechnology

About: Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Employees: 165